The Current Ratio as of December 2025 (TTM) for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) is 7.53

According to Jacobio Pharmaceuticals Group Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 7.53. This represents a change of 24.85% compared to the average of 6.03 of the last 4 quarters.

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) Historical Current Ratio (quarterly & annually)

How has 1167.HK Current Ratio performed in the past?

The mean historical Current Ratio of Jacobio Pharmaceuticals Group Co., Ltd. over the last ten years is 13.52. The current 7.53 Current Ratio has changed 5.47% with respect to the historical average. Over the past ten years (40 quarters), 1167.HK's Current Ratio was at its highest in in the December 2020 quarter at 24.57. The Current Ratio was at its lowest in in the June 2018 quarter at 0.

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Jacobio Pharmaceuticals Group Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) Average Current Ratio

How has 1167.HK Current Ratio performed in the past?

The current Current Ratio of Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) Current Ratio vs. Peers

How is 1167.HK’s Current Ratio compared to its peers?

Jacobio Pharmaceuticals Group Co., Ltd.’s Current Ratio is greater than Qyuns Therapeutics Co., Ltd. (1.51), greater than Viva Biotech Holdings (1.76), greater than TYK Medicines, Inc (1.97), greater than AIM Vaccine Co., Ltd. (0.73), greater than Jiangxi Rimag Group Co., Ltd. (2.42), greater than Ocumension Therapeutics (5.29), less than Medtide Inc. (0), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (3.33), greater than Tong Ren Tang Technologies Co. Ltd. (4.82), greater than Yidu Tech Inc. (6.24),

Build a custom stock screener for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jacobio Pharmaceuticals Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jacobio Pharmaceuticals Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.